CoChat

Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study

Open access
Akman, Ayse, Durusoy, Cicek, Senturk, Meltem, Koc, Cilem Kaya, Soyturk, Durali, Alpsoy, Erkan · 2007 · Archives of Dermatological Research
Cited by 92

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Oral isotretinoin is the most effective choice in the treatment of severe acne. Application of isotretionin to acne has been expanded to treat those patients with less severe but scarring acne who are responding unsatisfactorily to conventional therapies. However, its use is associated with many side effects, some of which can result in very disastrous consequences. Data related with intermittent isotretinoin therapy is still limited. Our aim was to asses the efficacy and tolerability of two different intermittent isotretinoin courses and compare them with conventional isotretinoin treatment. In this multicenter and controlled study, 66 patients with moderate to severe cases were randomized to receive either isotretionin for the first 10 days of each month for 6 months (group 1), or each day in the first month, afterwards the first 10 days of each month for 5 months (group 2) or daily for 6 months (group 3). The drug dosage was 0.5 mg/kg/day in all groups. Patients were followed-up for 12 months. Efficacy values were evaluable for 22 patients in group 1, 19 patients in group 2, and 19 patients in group 3. Acne scores in each group were significantly lower at the end of treatment and follow-up periods (P < 0.001). When patients were evaluated separately as moderate (n = 31) and severe (n = 29), no statistically significant differences were obtained among the treatment protocols in patients with moderate acne. However, there was a significant difference between groups 1 and 3 to the response of the treatments in severe acne patients at the end of follow-up period (P = 0.013). The frequency and severity of isotretionin-related side effects were found to be lower in groups 1 and 2 compared with group 3. Intermittent isotretinoin may represent an effective alternative treatment, especially in moderate acne with a low incidence and severity of side effects. The intermittent isotretinoin can be recommended in those patients not tolerating the classical dosage.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00403-007-0777-2

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 10

  1. Amichai B (2003) Long-term minidoses of isotretinoin in the treatment of relapsing acne. J Dermatol 30:572 · doi:10.1111/j.1346-8138.2003.tb00437.x
  2. Cunliffe WJ, Meynadier J, Alirezai M et al (2003) Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle. J Am Acad Dermatol 49:218–226 · DOI
  3. Gollnick HP, Graupe K, Zaumseil RP (2001) Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 11:538–544
  4. Goulden V, Clark SM, Mcgeown C, Cunliffe WJ (1997) Treatment of acne with intermittent isotretinoin. Br J Dermatol 137:106–108 · DOI · Paper page
  5. Kaymak Y, İlter N (2006) The effectiveness of intermittent isotretinoin treatment in mild or moderate acne. J Eur Acad Dermatol Venereol 20:1256–1260 · DOI · Paper page
  6. Layton AM, Dreno B, Gollnick HP, Zouboulis CC (2006) A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris. J Eur Acad Dermatol Venereol 20:773–776 · DOI · Paper page
  7. Mandekou-Lefaki I, Delli F, Teknetzis A, Euthimiadou R, Karakatsanis G (2003) Low-dose schema of isotretinoin in acne vulgaris. Int J Clin Pharmacol Res 23:41–46
  8. Palmer RA, Sidhu S, Goodwin PG (2000) ‘Microdose’ isotretinoin. Br J Dermatol 143:205–206 · DOI
  9. Seukeran DC, Cunliffe WJ (1998) Acne vulgaris in the elderly; the response to low-dose isotretinoin. Br J Dermatol 139:99–101 · DOI
  10. Struss JS, Leyden JJ, Lucky AW et al (2001) Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. J Am Acad Dermatol 45:196–207 · DOI

Cited by

See all 92

Metadata

Authors
Akman, A., Durusoy, C., Senturk, M., Koc, C. K., Soyturk, D., & Alpsoy, E.
Venue
Archives of Dermatological Research
Published
2007-08-21
Volume
299
Issue
10
Pages
467-473
ISSN
  • 0003-9187 (ISSN-L)
  • 0340-3696
  • 1432-069X
OpenAlex
W1983371617
Cited by
92
References
1
FWCI
5.87
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. https://app.cochat.ai/papers/10.1007/s00403-007-0777-2
The paper
Akman, A., Durusoy, C., Senturk, M., Koc, C. K., Soyturk, D., & Alpsoy, E. (2007). Treatment of acne with intermittent and conventional isotretinoin: a randomized, controlled multicenter study. Archives of Dermatological Research. https://doi.org/10.1007/s00403-007-0777-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.